ARTICLE |
Correspondence to: Gregory S. Hageman, Dept. of Ophthalmology and Visual Sciences, U. of Iowa, 11190E PFP, 200 Hawkins Drive, Iowa City, IA 52240.
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Ocular drusen are extracellular deposits that form between the retinal pigmented epithelium (RPE) and Bruch's membrane. Although the presence of large and/or numerous drusen in the macula is a significant risk factor for development of age-related macular degeneration (AMD), a major cause of irreversible blindness, little is known about their origin or composition. We have expanded on our previous investigations related to drusen-associated glycoconjugates by examining lectin binding patterns after removal of terminal sialic acid residues. Strikingly, intense and distinct labeling of drusen subdomains is revealed by Arachea hypogea agglutinin (PNA) after neuraminidase treatment. PNA binding is confined to discrete domains within both hard and soft drusen. These "cores" are positioned centrally within drusen and are typically juxtaposed to Bruch's membrane. Only one core per druse is observed. PNA labeling of drusen cores does not co-localize with associated lipids and is abrogated by digestion with O-glycosidase but not N-glycosidase. The association of cores with small drusen suggests that they may participate in drusen biogenesis. (J Histochem Cytochem 47:15331539, 1999)
Key Words: macular degeneration, drusen, glycoconjugates, lectins, peanut agglutinin
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Drusen are pathological deposits that accumulate between the retinal pigmented epithelium (RPE) basal lamina and the inner collagenous layer of Bruch's membrane in aging human eyes. The size, number, and/or degree of confluence of drusen sclerad to the macular RPE are established risk factors for the development of age-related macular degeneration (AMD), a leading cause of irreversible blindness worldwide (
A number of studies have focused on characterizing the structure of drusen, largely in attempts to classify their phenotype. However, relatively little is known about their composition and/or genesis. One commonly held view, supported by a number of clinicopathological studies, is that small "hard" drusen are precursors of large "soft" drusen (
One impediment encountered in efforts to determine the origin of drusen relates to our overall lack of knowledge about their composition. To date, only a few studies have sought to identify and/or characterize drusen-associated proteins (
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Reagents
Reagents and supplies were purchased from the following sources. From EY Laboratories (San Mateo, CA) and Vector Laboratories (Burlingame, CA): fluorescein isothiocyanate (FITC)- and rhodamine-conjugated Limax flavus agglutinin (LFA), Triticum vulgaris agglutinin (WGA), Canavalia ensiformis agglutinin (ConA), and Arachea hypogea agglutinin (PNA). From BoehringerMannheim (Indianapolis, IN): neuraminidase (EC3.2.1.18; cleaves 2,3-,
2,6-, and
2,8 -ketosidic bonds) derived from Clostridium perfringens. From Genzyme (Cambridge, MA): endo-
-N-acetylgalactosaminidase. From Sigma Chemical (St Louis, MO): peptide:N-glycosidase F and globulin-free bovine serum albumin (BSA). From Molecular Probes (Eugene, OR): 4',6-diamidino-2-phenylindole (DAPI). From Poly Scientific (Bay Shore, NY): Sudan black B solution. From Bethesda Research Laboratories (Bethesda, MD): acrylamide and other reagents used for embedding. From Miles (Elkhart, IN): Optimal Cutting Temperature (OCT) compound. From Fisher Scientific (Pittsburgh, PA): Superfrost Plus slides.
Human Donor Eyes
Eyes with drusen from 61 human donors, 35 to 101 years of age, were obtained from the Iowa Lions Eye Bank (Iowa City, IA). Eyecups were preserved either in 4% paraformaldehyde in 100 mM sodium cacodylate, pH 7.4, or embedded directly in OCT compound and frozen in liquid nitrogen, without fixation, within 6 hr post mortem. Institutional Review Board approval was obtained from the Human Subjects Committee for the use of all donor tissues.
Fixation and Embedding
After 24 hr in fixative, eyecups were washed twice for 10 min in 100 mM cacodylic acid, pH 7.4, and wedges spanning from the macula to the ora serrata were dissected and embedded in acrylamide embedding media, as described previously (
Glycosidase Treatment
Sections of fixed and unfixed tissues were incubated overnight with 1 U/ml neuraminidase in 30 mM sodium acetate buffer, pH 5, at 37C in a humidified chamber. Sections from 61 eyes, 52 fixed and acrylamide-embedded and nine unfixed and OCT-embedded, were treated with neuraminidase and then labeled with FITC- or rhodamine-conjugated PNA. Adjacent control sections were incubated with buffer alone or with FITC. Serial sections from two eyes (one fixed and one unfixed) were treated with neuraminidase and labeled with LFA, ConA, and WGA to determine the effects of neuraminidase on labeling of drusen with other lectins. Fixed tissue sections from two additional donors were pretreated with neuraminidase and then treated with endo--N-acetylgalactosaminidase (O-glycanase, 1 U/ml in 15 mM sodium cacodylate, pH 6) or peptide:N-glycosidase F (PNGase F, 1 U/ml in PBS) for 72 hr at 37C. Control sections were treated with buffer alone.
Lectin Histochemistry
For lectin labeling, 68-µm-thick cryostat sections were cut, mounted on Superfrost Plus slides, labeled with PNA, WGA, ConA, or LFA as described previously (
To compare labeling of enzyme- and buffer-treated sections, intensity and binding patterns on serial sections containing the same drusen were compared. Identical exposure times for experimental pairs were used during photomicrography and photographic processing.
Quantitation
The percentage of drusen cores was determined in eyes obtained from three donors. Stepped sections were collected at 60-µm intervals to avoid sampling the same core more than once and were pretreated with neuraminidase and labeled with FITCPNA as described above. The numbers of cores in a total of 501 drusen were counted.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Neuraminidase Treatment
Incubation of drusen-containing tissue sections with neuraminidase completely eliminated LFA labeling of drusen and other structures in the chorioretinal complex compared with controls. This loss of drusen labeling was used throughout the study to control for the efficacy of the enzyme treatment (Figure 1A and Figure 1B) as were changes in labeling of the interphotoreceptor matrix, as described previously (
|
Labeling of drusen with WGA and ConA was not significantly diminished after neuraminidase treatment (Figure 1C and Figure 1D), demonstrating that the binding of these lectins with drusen-associated glycoconjugates is not primarily due to sialic acid. In some eyes, the intensity of WGA labeling of the choroidal stroma and neural retina decreased after neuraminidase treatment without a concomitant loss of WGA binding to drusen in the same section (Figure 1D).
As described previously (
Strikingly, some drusen were labeled intensely by PNA after exposure to neuraminidase. This labeling was restricted to distinct subdomains or "cores" within drusen (Figure 1F). These cores were not observed in adjacent sections treated with buffer alone (Figure 1E). Drusen cores were typically spherical, centrally located within the druse, and juxtaposed to the inner collagenous layer of Bruch's membrane. Only one core was observed within any given solitary druse. Cores were not regularly observed within larger diffuse or confluent drusen. The sizes of drusen cores ranged from 5 to 38 µm in diameter, with a mean diameter of 14 µm. Both hard and soft drusen possessed cores, although large soft drusen typically had PNA binding cores that were larger and less centrally localized than those of hard drusen (e.g., Figure 2C and Figure 2D). Cores were found in donors exhibiting a variety of ultrastructural drusen phenotypes (
|
Drusen cores were observed frequently; in this study, cores were observed in 45 of 61 eyes examined. No differences in the appearance, relative size, and/or frequency of these deposits was noted with respect to fixation and embedding regimens. Intense labeling of drusen cores was observed using both FITCPNA and rhodamine-conjugated PNA, demonstrating that this observation is not strictly due to the interaction of drusen with the fluorophore. Although drusen fluoresced when incubated with FITC alone, this binding was not associated with core subdomains. The percentage of cores was determined in three donors. Cores were observed in 22.2, 29.7, and 33.7% of drusen in each of the three donors. From a combined total of 501 drusen, 134 exhibited cores (26.7%). Twelve small (<60-µm) drusen were bound in their entirety by PNA (2.4%).
Enzymatic Characterization of Drusen Cores
After sequential incubation of tissue sections with neuraminidase and O-glycanase, PNA labeling of drusen cores was significantly reduced (Figure 2A and Figure 2B). Labeling of the choroid and interphotoreceptor matrix was nearly or completely abrogated after O-glycanase treatment (not shown). O-Glycanase treatment had little effect on labeling of rod outer segments with ConA, suggesting that contaminating N-glycosidase activity was not present (not shown). In contrast to O-glycanase treatment, PNGase F pretreatment did not change the intensity of PNA labeling of drusen cores (Figure 2C and Figure D). ConA labeling of rod outer segments was completely abrogated after incubation with PNGase F, demonstrating that the enzyme efficiently removed N-linked glycans (not shown).
When examined under UV fluorescence optics, drusen cores were frequently less autofluorescent than the rest of the druse in both PNA-labeled and unlabeled tissue sections (Figure 3B). DAPI, a DNA-specific probe, did not label cores (Figure 3B). In addition, the lipid stain Sudan black B did not bind to drusen cores (Figure 3 C), although the remainder of the druse was stained.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We noted previously that some drusen possess heterogeneously distributed glycoconjugates (
The observations that PNA binds discrete drusen subdomains (drusen cores) after neuraminidase treatment and that LFA, a sialic acid binding lectin, does not bind specifically to drusen cores suggest that at least two distinct classes of terminal sialic acid-containing glycoconjugates are present in drusen and that they are distributed in different regions of drusen.
The PNA binding disaccharides (galactose ß1,3 N-acetylgalactosamine) is frequently associated with O-glycosidically linked sugars but is also associated with some gangliosides (
In summary, we have identified a carbohydrate moiety that, in contrast to other drusen-associated glycoconjugates that have been described, is localized to novel, discrete basal subdomains, or cores, within drusen. Although previously unrecognized, these cores are common components of drusen and appear to be composed of glycoproteins with O-glycosidically linked carbohydrate chains. Whereas sialic acid residues, as assessed by LFA binding, are distributed throughout drusen, at least one distinct glycoprotein possessing PNA binding epitopes that are masked by sialic acid is localized to these structures.
It is conceivable that drusen cores develop late in drusen ontogeny, although this is not strongly supported by our data. We propose that it is more likely that these subdomains are related to drusen biogenesis. The observations that solitary drusen have only one core and that these cores are typically located centrally and basally within drusen suggest that they may represent an early nucleation site around which other drusen-associated molecules are subsequently deposited. The remaining constituents of drusen, including lipids, would be deposited around the core. This contention is consistent with the observations that small PNA-positive structures are frequently visualized beneath the RPE and that larger confluent/diffuse drusen are less likely to have cores than smaller drusen.
We propose that the identification of the precise biological identity and source(s) of drusen core-associated glycoproteins may provide new insights into the genesis of drusen and into the etiology of age-related macular degeneration. Ongoing efforts are being directed towards this goal.
![]() |
Acknowledgments |
---|
Supported in part by NIH grants EY06463 (GSH), EY11515 (GSH), and by an unrestricted grant to the University of Iowa Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness, Inc. GSH is the recipient of the RPB Lew R. Wassarman Merit Award.
We thank Dr Stephen Russell for evaluation of donor eye tissues, Markus Kuehn for helpful discussions, and Bobbie Schneider, Cory Speth, Heidi Nienhaus, and Lisa Thayer for superb technical assistance.
Received for publication April 2, 1999; accepted June 14, 1999.
![]() |
Literature Cited |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Bird A (1992) Pathophysiology of AMD. In Hampton G, Nelsen PT, eds. Age-related Macular Degeneration: Principles and Practice. New York, Raven Press, 63-83
Bressler S, Maguire G, Bressler N, Fine S (1990) Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 108:1442-1447[Abstract]
Burns R, Feeney Burns L (1980) Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc 78:206-225[Medline]
El Baba F, Green W, Fleischmann J, Finkelstein D, de la Cruz Z (1986) Clinicopathologic correlation of lipidization and detachment of the retinal pigment epithelium. Am J Ophthalmol 101:576-583[Medline]
Farkas T, Sylvester V, Archer D (1971) The ultrastructure of drusen. Am J Ophthalmol 71:1196-1205[Medline]
Fine B (1981) Lipoidal degeneration of the retinal pigment epithelium. Am J Ophthalmol 91:469-473[Medline]
Friedman E, Smith T, Kuwabara T (1963) Senile choroidal vascular patterns and drusen. Arch Ophthalmol 69:220-230[Medline]
Hageman G, Mullins R (in press) Molecular composition of drusen as related to substructural phenotype. Mol Vis
Hageman G, Mullins R, Russell S, Johnson L, Anderson D (1999) Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J 13:477-484
Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan S (1986a) Formation of drusen in the human eye. Am J Ophthalmol 101:342-353[Medline]
Ishibashi T, Sargente N, Patterson R, Ryan S (1986b) Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci 27:184-193[Abstract]
Johnson L, Blanks J (1984) Application of acrylamide as an embedding medium in studies in lectin and antibody binding in the vertebrate retina. Curr Eye Res 3:969-974[Medline]
Johnson L, Hageman G (1987) Enzymatic characterization of peanut agglutinin-binding components in the retinal interphotoreceptor matrix. Exp Eye Res 44:553-565[Medline]
Kincaid M (1992) Pathology of AMD. In Hampton G, Nelsen P, eds. Age-related Macular Degeneration: Principles and Practice. New York, Raven Press, 37-62
Kivela T (1990) Characterization of galactose-containing glycoconjugates in the human retina: a lectin histochemical study. Curr Eye Res 9:1195-1209[Medline]
Kliffen M, Mooy C, Luider T, de Jong P (1994) Analysis of carbohydrate structures in basal laminar deposit in aging human macula. Invest Ophthalmol Vis Sci 35:2901-2905[Abstract]
Kliffen M, Mooy C, Luider T, Huijmans J, Kerkvliet S, de Jong P (1996) Identification of glycosaminoglycans in age-related macular deposits. Arch Ophthalmol 114:1009-1014[Abstract]
Mullins R, Johnson L, Anderson D, Hageman G (1997) Characterization of drusen-associated glycoconjugates. Ophthalmology 104:288-294[Medline]
Newsome D, Hewitt A, Huh W, Robey P, Hassell J (1987) Detection of specific extracellular matrix molecules in drusen, Bruch's membrane, and ciliary body. Am J Ophthalmol 104:373-381[Medline]
Pauleikhoff D, Barondes M, Minassian D, Chisholm I, Bird A (1990) Drusen as risk factors in age-related macular disease. Am J Ophthalmol 109:38-43[Medline]
Pauleikhoff D, Zuels S, Sheraidah G, Marshall J, Wessing A, Bird A (1992) Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology 99:1548-1553[Medline]
Sarks S (1982) Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol 10:91-97[Medline]
Sarks J, Sarks S, Killingsworth M (1994) Evolution of soft drusen in age-related macular degeneration. Eye 8:269-283[Medline]
Sarks S, Van Driel D, Maxwell L, Killingsworth M (1980) Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc UK 100:414-422[Medline]
Sheraidah G, Steinmetz R, Maguire J, Pauleikhoff D, Marshall J, Bird A (1993) Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology 100:47-51[Medline]
Umemoto J, Bhavanandan V, Davidson E (1977) Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae. J Biol Chem 252:8609-8614[Abstract]
van der Schaft T, Mooy C, de Bruijn W, de Jong P (1993) Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol 77:657-661[Abstract]
Vinding T (1990) Occurrence of drusen, pigmentary changes and exudative changes in the macula with reference to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Opthalmol 68:410-414
Zeller C, Marchase R (1992) Gangliosides as modulators of cell function. Am J Physiol 262:C1341-1355